Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application
✍ Scribed by Efraim H. Rosenberg; Cristina Martínez Muñoz; Ofir T. Betsalel; Silvy J.M. van Dooren; Matilde Fernandez; Cornelis Jakobs; Ton J. deGrauw; Tjitske Kleefstra; Charles E. Schwartz; Gajja S. Salomons
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 288 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
✦ Synopsis
Creatine transporter deficiency is an X-linked mental retardation disorder caused by mutations in the creatine transporter gene (SLC6A8). So far, 20 mutations in the SLC6A8 gene have been described. We have developed a diagnostic assay to test creatine uptake in fibroblasts. Additionally, we expanded the assay to characterize novel SLC6A8 missense variants. A total of 13 variants were introduced in the SLC6A8 cDNA by site-directed mutagenesis. All variants were transiently transfected in SLC6A8-deficient fibroblasts and tested for restoration of creatine uptake in deficient primary fibroblasts. Thus, we proved that nine variants (p.Gly87Arg, p.Phe107del, p.Tyr317X, p.Asn336del, p.Cys337Trp, p.Ile347del, p.Pro390Leu, p.Arg391Trp, and p.Pro554Leu) are pathogenic mutations and four variants (p.Lys4Arg, p.Gly26Arg, p.Met560Val, and p.Val629Ile) are nonpathogenic. The present study provides an improved diagnostic tool to classify sequence variants of unknown significance.